Rhophylac
Rho(D) immune globulin (Rho(D) IG) (injectable) (ROW D ih MUNE GLAW byoo lin)
BayRHo-D, Gamulin Rh, HypRho-D Mini-Dose, MicRhoGAM, Mini-Gamulin Rh, RhoGAM, Rhophylac, WinRho SDF
What is the most important information I should know about Rhophylac?
|
|
• |
Rhophylac is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although Rhophylac is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using Rhophylac. |
|
• |
Rho(D) immune globulin (Rho(D) IG) is a sterilized solution obtained from pooled human blood. Rh is an antigen in the blood that is either present or absent (blood type Rh positive or Rh negative). If an Rh negative individual is exposed to blood that is Rh positive through pregnancy (the baby has an Rh positive blood type) or a blood transfusion, the individual may develop an immune response to the Rh positive blood. |
|
• |
Rhophylac is used to prevent an immune response to Rh positive blood in people with an Rh negative blood type. Rhophylac may also be used in the treatment of immune thrombocytopenic purpura (ITP). |
|
• |
Rhophylac may also be used for purposes other than those listed here. |
What should I discuss with my healthcare provider before taking Rhophylac?
|
|
• |
Do not use Rhophylac without first talking to your doctor if you have |
|
· |
had your spleen removed; |
|
· |
a low level of platelets in the blood or a bleeding disorder; |
|
· |
had a previous allergic reaction to an immune globulin. |
|
• |
You may not be able to use Rhophylac, or you may require a dosage adjustment or special monitoring during treatment. |
|
• |
Rhophylac is in the FDA pregnancy category C. This means that it is not known whether it will be harmful to an unborn baby. Do not use Rhophylac without first talking to your doctor if you are pregnant or could become pregnant during treatment. |
|
• |
It is not known whether Rhophylac passes into breast milk. Rhophylac administered following childbirth is not expected to affect a nursing baby. |
How should I take Rhophylac?
|
|
• |
Rhophylac will be administered by intramuscular (into a muscle) or intravenous (into a vein) injection by a healthcare provider in a hospital or clinic setting. If Rhophylac is being administered at home, your healthcare provider will give you detailed administration instructions. |
|
• |
Your doctor may want you to have blood tests or other forms of monitoring during treatment with Rhophylac to monitor progress and side effects. |
|
• |
Your healthcare provider will store Rhophylac as directed by the manufacturer. If you are storing Rhophylac at home, your healthcare provider will provider storage instructions. |
What happens if I miss a dose?
|
|
• |
Contact your doctor if a dose of Rhophylac is missed. |
What happens if I overdose?
|
|
• |
Seek emergency medical attention or contact your healthcare provider if an overdose of Rhophylac is suspected. |
|
• |
No information is available regarding an overdose of Rhophylac. |
What should I avoid while taking Rhophylac?
|
|
• |
Do not receive vaccines that use live strains of the virus (e.g., measles, mumps, and rubella or MMR) during and for approximately three months following treatment with Rhophylac. These vaccines may not work properly when Rhophylac has been recently administered. |
What are the possible side effects of Rhophylac?
|
|
• |
Rhophylac is made from human plasma (part of the blood) and may contain infectious agents (e.g., viruses) that can cause disease. Although Rhophylac is screened, tested, and treated to reduce the possibility that it carries an infectious agent, it can still potentially transmit disease. Discuss with your doctor the risks and benefits of using Rhophylac. |
|
• |
Notify your doctor immediately if you experience a rare but serious allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives) to Rhophylac. |
|
• |
Other less serious side effects may also occur. Notify your doctor if you experience |
|
· |
pain or tenderness at the injection site. |
|
• |
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. |
What other drugs will affect Rhophylac?
|
|
• |
Do not receive vaccines that use live strains of the virus (e.g., measles, mumps, and rubella or MMR) during and for approximately three months following treatment with Rhophylac. These vaccines may not work properly when Rhophylac has been recently administered. |
|
• |
It is not known whether other medications will interact with Rhophylac. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including herbal products during treatment with Rhophylac. |
Where can I get more information?
|
|
• |
Your pharmacist has additional information about Rhophylac written for health professionals that you may read. |
|
• |
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. |
|
• |
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Click here for more information on Rhophylac from the manufacturer.
|
Copyright 1996-2004 Cerner Multum, Inc. Version: 1.05. Revision date: 6/4/04.